Gene Therapy Shows Promise in Treating Neuropathy From Spina

Gene therapy that inhibits targeted nerve cell signals effectively improves symptoms of neuropathic pain without negative side effects in mouse models of spinal cord injury or peripheral nerve damage.

Related Keywords

Japan , Slovak Republic , Salk Institute , California , United States , Thailand , Czech Republic , San Diego , Kyiv , Kyyiv , Misto , Ukraine , Ryukyus , Okinawa , University Of California San Diego , Czech , Slovak , Thomasd Glenn , Stefan Juhas , Shawnp Driscoll , Kirill Agashkov , Taratorn Kemthong , Martin Marsala , Volodymyr Krotov , Samuell Pfaff , Oleksandr Platoshyn , Ivo Vanicky , Tetsuya Yoshizumi , Pavel Belan , Helena Kupcova Skalnikova , Joseph Ciacci , Silvia Marsala , Jan Motlik , Suchinda Malaivijitnond , Yoshiomi Kobayashi , Atsushi Miyanohara , Duong Nguyen , Manabu Kakinohana , Takahiro Tadokoro , Jana Juhasova , Rajiv Reddy , Mariana Bravo Hernandez , Michael Navarro , Michiko Shigyo , Czech Academy Of Sciences , Kyiv Academic University , Department Of Anesthesiology , University Of Ryukyus , Salk Institute For Biological , Bogomoletz Institute Of Physiology , Slovak Academy Of Sciences , Chulalongkorn University , Uc San Diego School Of Medicine , California San Diego School , Molecular Therapy , Diego School , Neurgain Technologies , Bogomoletz Institute , Czech Academy , Biological Studies , Zoltan Tomori , Slovak Academy , Scott La Fee , Neuroscience Newsletter ,